Loading clinical trials...
Loading clinical trials...
The purpose of this study is to assess the risks of abuse, misuse and adverse events related to high dose buprenorphine. Approximately 1250 patients taking Subutex (Schering-Plough) or its Buprenorphi...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Indivior Inc.
NCT05790252 · Opioid Use Disorder, Pregnancy Related, and more
NCT05505227 · Opioid-Related Disorders, Buprenorphine, and more
NCT06880718 · Opioid Use Disorder, Incarceration, and more
NCT06251609 · Heart Arrest, Out-Of-Hospital, Opioid Overdose, and more
NCT06063499 · Opioid Use Disorder, Opioid Use, and more
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions